CN1060079C - Chinese herbal medicine composition for curing leukemia - Google Patents

Chinese herbal medicine composition for curing leukemia Download PDF

Info

Publication number
CN1060079C
CN1060079C CN97108407A CN97108407A CN1060079C CN 1060079 C CN1060079 C CN 1060079C CN 97108407 A CN97108407 A CN 97108407A CN 97108407 A CN97108407 A CN 97108407A CN 1060079 C CN1060079 C CN 1060079C
Authority
CN
China
Prior art keywords
herbal medicine
chinese herbal
rhizome
medicine composition
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97108407A
Other languages
Chinese (zh)
Other versions
CN1188012A (en
Inventor
任玉让
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97108407A priority Critical patent/CN1060079C/en
Publication of CN1188012A publication Critical patent/CN1188012A/en
Application granted granted Critical
Publication of CN1060079C publication Critical patent/CN1060079C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention belongs to a Chinese herbal medicine composition for curing leukemia. The Chinese herbal medicine composition with the functions of strengthening the spleen, tonifying the kidney and clearing heat is adopted according to different symptoms of leukemia patients in different pathogenic periods, and the medication is flexibly regulated for matched application. Four groups of recipes are composed of more than 30 kinds of Chinese herbal medicine such as pilose asiabell root, astragalus root, white atractylodes rhizome, tuckahoe, dried tangerine peel, nutgrass galingale rhizome, bupleurum root, lalang grass rhizome, atractylodes rhizome, monkshood, dried ginger, cassia twig, prepared rhizome of rehmannia, cornaceae, etc. Clinical application proves that the curative ratio of the present invention reaches 94%.

Description

Treat leukemic herbal composite
The present invention relates to treat leukemic herbal composite, belong to the Chinese medicine technical field.
Leukemia is one of more refractory disease of blood system.Doctor trained in Western medicine generally adopts chemotherapy at present, and the toxic and side effects that chemotherapy produced to the human body infringement greatly, and the patient often can not get satisfied effect, but causes adverse consequencess such as health immunologic hypofunction on the contrary.For avoiding the western medical treatment defective, in China medical circles once the someone release with the leukemic scheme of controlling of executing of herbal composite treatment, but the problem one that exists in compatibility of drugs is the organic connections of having ignored the human five internal organs, compatibility of drugs is unreasonable, so that pharmacology is obstructed; The 2nd, stick to a side one disease, be confined to the symptom performance in a certain stage of patient disease and only play single heat clearing away, yin nourishing, invigorate blood circulation, benefiting action, therefore can not reach the leukemic purpose of effective treatment.
Goal of the invention of the present invention is to avoid and overcomes above-mentioned the deficiencies in the prior art and release a kind of with the effective leukemic herbal composite of treatment of strengthening spleen, tonifying kidney clearing away heat method.In treatment, be not limited to a side one disease, adopt spleen invigorating, the kidney invigorating, heat clearing away to use simultaneously; Or based on heat clearing away, or based on the kidney invigorating, or based on spleen invigorating.Be that the kidney invigorating heat clearing away is not forgotten in spleen invigorating, the spleen invigorating heat clearing away is not forgotten in the kidney invigorating, and heat clearing away does not forget to nurse one's health the spleen kidney.Demonstrate fully dialectical with debate disease organic synthesis dialectical opinion together and control thought.
Goal of the invention of the present invention can be achieved by the following technical programs: because leukemia shows anemia, hemorrhage, infection three big symptoms clinically, it is generally acknowledged how this disease is caused by factors such as ionizing radiation, chemical substance and virus, heredity, immunity, body fluid.By clinical observation for many years, according to the pathogen and pathology of tcm theory, think that this disease is by plain body spleen kidney deficiency, lose in the healthy energy, the pathogen invasion, with the passing of time heat-transformation, evil poison is invaded blood, flows into bone marrow, influences function of five internal organs and forms.The kidney governing bones marrow, splenaemia.Leukemia disease feelings complexity, the pathogenesis deficiency syndrome mingling with excess syndrome, in line with starting with from the spleen kidney, the principle of the heat clearing away heresy of holding concurrently can be effective when clinical treatment.So acute and chronic leukemia no matter: if asthenia of both the spleen and kidney appears in the patient, symptomes complices such as pathogenic heat remaining in the interior, the composition of the herbal composite that should adopt and shared weight hundred are than being: who ground 6%, the Radix Rehmanniae 6%, Cortex Phellodendri 6%, the Rhizoma Anemarrhenae 6%, mountain cornel 6%, Cortex Lycii 6%, Radix Codonopsis 6%, Rhizoma Polygonati 6%, the Radix Paeoniae Alba 6%, Rhizoma Dioscoreae 6%, Rhizoma Imperatae 6%, Herba Scutellariae Barbatae 10%, Radix Angelicae Sinensis 6%, the Radix Astragali 11%, Rhizoma Coptidis 3%.
Good effect of the present invention is: first has avoided the infringement of the toxic and side effects of doctor trained in Western medicine chemotherapy to human body; The second spleen kidney deficiency according to the clinical appearance of patient, that accumulates in the pathogenic heat is ripe light ripe heavy, adopts the principle of medication of strengthening spleen, tonifying kidney heat clearing away, organically combines debating disease and debating disease.And be not limited to a side one disease.Having used the present invention since 90 years treats the numerical example patient and obtains beyond thought therapeutic effect.As following table:
Age group Number Alleviate fully Part is alleviated
Under-18s The man 6 6
The woman 3 3
19-49 year The man 6 6
The woman 2 2
More than 50 years old The man 1 1
The woman
Add up to 18 17 1
Alleviate fully: 17 examples, cure rate accounts for 94%;
Part is alleviated: 1 example accounts for 6%
Embodiment: according to theory of Chinese medical science kidney governing bones marrow, The spleen governs the blood, establishing principle of the present invention is that conditioning spleen kidney is main, the heat clearing away heresy of holding concurrently simultaneously.Adopt spleen invigorating, the kidney invigorating, heat clearing away to use simultaneously, pay attention to spleen kidney and the effect of evil poison in each pathological process of leukemia.The spleen kidney deficiency, in the healthy energy thanks to be this disease this, pathogen invasion, with the passing of time heat-transformation, evil poison is invaded blood system, flows in bone marrow, the infringement function of five internal organs is the target pathology thought of primary disease,
If the patient is asthenia of both the spleen and kidney, pathogenic heat remaining in the interior person, then should select following herbal composite of the present invention for use:
Who ground 10g, Radix Rehmanniae 10g, Cortex Phellodendri 10g, Rhizoma Anemarrhenae 10g, mountain cornel 10g, Cortex Lycii 10g, Radix Codonopsis 10g, Rhizoma Polygonati 10g, Radix Paeoniae Alba 10g, Rhizoma Dioscoreae 10g, Rhizoma Imperatae 10g, Herba Scutellariae Barbatae 15g, Radix Angelicae Sinensis 10g, Radix Astragali 18g, Rhizoma Coptidis 5g.
Instructions of taking of the present invention is to be decocted in water for oral dose, 1 day 1 dose, morning and evening service once, 10 doses was 1 course of treatment.
Medical record is given an example: Zhao * *, woman, 13 years old.The Shunyi County people of Beijing, 1988 is " leukemia " at Beijing hospital diagnosis, successively in Tianjin, ground treatment unsatisfactory curative effects such as Beijing, Xi'an.Going to a doctor in the here of coming March 10 nineteen ninety, examines its pale complexion, spiritlessness and weakness.The lazy speech of breathing hard, cardiopalmus, soreness of the waist and knees, eyelid is pale, the bluish lip purple, bleeding from the gum, the time epistaxis, thirsty, light red tongue, tongue is greasy in vain, thready and rapid pulse.Laboratory examination: WBC107.0 * 10 9/ L, RBC1.4 * 10 12/ L, Hb40g/L, mirror hematochezia sheet is found original and juvenile white cell.The remarkable hypertrophy of bone marrow smear, leukemia germinal cell are up to 67%, and cell peroxidating stone roller karyomere cell series monocytic series is classified the positive as, and lymphocyte is tied to negative, is diagnosed as " chronic leukemia acute attack ".Disease belongs to asthenia of both the spleen and kidney, pathogenic heat remaining in the interior.Use above-mentioned composition of the present invention, adjust to use with disease, use 10 courses of treatment continuously after, patient's spirit is good, appetite increases, and has not felt weak, 10 doses of the band medicines of continuing to consolidate curative effect, are followed up a case by regular visits to not recurrence again in 3 years.
The present invention shows through zoopery, has no side effect and other untoward reaction.

Claims (1)

1, the leukemic herbal composite of a kind of treatment is characterized in that the composition of said composition and shared percentage by weight are:
Who ground 6% Radix Rehmanniae, 6% Cortex Phellodendri, 6% Rhizoma Anemarrhenae 6%
Mountain cornel 6% Cortex Lycii 6% Radix Codonopsis 6% Rhizoma Polygonati 6%
The Radix Paeoniae Alba 6% Rhizoma Dioscoreae 6% Rhizoma Imperatae 6% Herba Scutellariae Barbatae 10%
Radix Angelicae Sinensis 6% Radix Astragali 11% Rhizoma Coptidis 3%.
CN97108407A 1997-01-17 1997-01-17 Chinese herbal medicine composition for curing leukemia Expired - Fee Related CN1060079C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97108407A CN1060079C (en) 1997-01-17 1997-01-17 Chinese herbal medicine composition for curing leukemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97108407A CN1060079C (en) 1997-01-17 1997-01-17 Chinese herbal medicine composition for curing leukemia

Publications (2)

Publication Number Publication Date
CN1188012A CN1188012A (en) 1998-07-22
CN1060079C true CN1060079C (en) 2001-01-03

Family

ID=5170397

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97108407A Expired - Fee Related CN1060079C (en) 1997-01-17 1997-01-17 Chinese herbal medicine composition for curing leukemia

Country Status (1)

Country Link
CN (1) CN1060079C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1098698C (en) * 1998-07-31 2003-01-15 张发誉 Medicinal pill for treating leukemia
CN1094058C (en) * 1999-06-02 2002-11-13 湖南医科大学附属湘雅医院 Tolerant Chinese medicine preparation for treating leukemia

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
中医杂志1987,28(10) 1987.1.1 吴正翔等,靛玉红与中药联用治疗慢性粒细胞白血病40例对比 *
中西医结合杂志1984(4) 1984.1.1 张亭栋等,癌灵1号治疗急性粒细胞白血病临床分析及实验研究 *
中西医结合杂志1984(4) 1984.1.1 张亭栋等,癌灵1号治疗急性粒细胞白血病临床分析及实验研究;中医杂志1987,28(10) 1987.1.1 吴正翔等,靛玉红与中药联用治疗慢性粒细胞白血病40例对比 *

Also Published As

Publication number Publication date
CN1188012A (en) 1998-07-22

Similar Documents

Publication Publication Date Title
Wang et al. Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine
CN101284121B (en) Combination medicine for curing the hoary hair
CN100496586C (en) Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion
CN100434107C (en) Acne clearing decoction
CN101195001A (en) Chinese medicine prescription for treating hypertension, hypercholesterolemia and hyperglycemia
CN1062157C (en) Hepatitis B curing toxin-dissipating pill
CN1131053C (en) Chinese medicine for treating diabetes
CN101347601A (en) Chinese medicine for treating gynecology disease and preparation method thereof
CN101164593A (en) Oral liquid for treating kidney disease
CN102614442A (en) Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis
CN101670089A (en) Traditional Chinese medicine for treating acute gastroenteritis
CN101675967A (en) Lupus I traditional Chinese medicine composition
CN103623385B (en) A kind of Chinese medicine for the treatment of oral ulcer
CN1060079C (en) Chinese herbal medicine composition for curing leukemia
CN102335336A (en) Traditional Chinese medicine for treating lupus sebaceus
CN1351872A (en) Chinese herbal medicine for curing comedo and acne
CN100579544C (en) Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof
CN103656595A (en) Traditional Chinese medicine composition for treating metrorrhagia
CN1686227A (en) Menstruation regulating powder
CN102397438A (en) Medicine for treating low renal function
CN103071079B (en) Traditional Chinese medicinal composition for treating prurigo nodularis
CN1260209A (en) Medicine for nephritis
CN101062245A (en) Chinese traditional medicine agent for treating children nephropathy syndrome
CN1583073A (en) Chinese patent medicinal prescription for catch-cold
CN102614420A (en) Chinese medicine preparation for curing atrophic glossitis

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee